Treatment of scleromyxedema with 2-chlorodeoxyadenosine

Loretta S Davis, Salahattin Sanal, Omar P. Sangueza

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Scleromyxedema is an unusual skin disease that is characterized by a proliferation of fibroblasts and an accumulation of mucin. Despite experience with multiple forms of therapy, no single agent has proved uniformly beneficial in this condition. We describe a patient with scleromyxedema who was treated successfully with 2-chlorodeoxyadenosine (2-CdA), a purine analog used mainly in the treatment of lymphoproliferative disorders.

Original languageEnglish (US)
Pages (from-to)288-290
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume35
Issue number2 II
DOIs
StatePublished - Jan 1 1996

Fingerprint

Scleromyxedema
Cladribine
Lymphoproliferative Disorders
Mucins
Skin Diseases
Fibroblasts
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Treatment of scleromyxedema with 2-chlorodeoxyadenosine. / Davis, Loretta S; Sanal, Salahattin; Sangueza, Omar P.

In: Journal of the American Academy of Dermatology, Vol. 35, No. 2 II, 01.01.1996, p. 288-290.

Research output: Contribution to journalArticle

Davis, Loretta S ; Sanal, Salahattin ; Sangueza, Omar P. / Treatment of scleromyxedema with 2-chlorodeoxyadenosine. In: Journal of the American Academy of Dermatology. 1996 ; Vol. 35, No. 2 II. pp. 288-290.
@article{0dce01857e2b4bc79be469dbf2df196e,
title = "Treatment of scleromyxedema with 2-chlorodeoxyadenosine",
abstract = "Scleromyxedema is an unusual skin disease that is characterized by a proliferation of fibroblasts and an accumulation of mucin. Despite experience with multiple forms of therapy, no single agent has proved uniformly beneficial in this condition. We describe a patient with scleromyxedema who was treated successfully with 2-chlorodeoxyadenosine (2-CdA), a purine analog used mainly in the treatment of lymphoproliferative disorders.",
author = "Davis, {Loretta S} and Salahattin Sanal and Sangueza, {Omar P.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/S0190-9622(96)90650-7",
language = "English (US)",
volume = "35",
pages = "288--290",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2 II",

}

TY - JOUR

T1 - Treatment of scleromyxedema with 2-chlorodeoxyadenosine

AU - Davis, Loretta S

AU - Sanal, Salahattin

AU - Sangueza, Omar P.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Scleromyxedema is an unusual skin disease that is characterized by a proliferation of fibroblasts and an accumulation of mucin. Despite experience with multiple forms of therapy, no single agent has proved uniformly beneficial in this condition. We describe a patient with scleromyxedema who was treated successfully with 2-chlorodeoxyadenosine (2-CdA), a purine analog used mainly in the treatment of lymphoproliferative disorders.

AB - Scleromyxedema is an unusual skin disease that is characterized by a proliferation of fibroblasts and an accumulation of mucin. Despite experience with multiple forms of therapy, no single agent has proved uniformly beneficial in this condition. We describe a patient with scleromyxedema who was treated successfully with 2-chlorodeoxyadenosine (2-CdA), a purine analog used mainly in the treatment of lymphoproliferative disorders.

UR - http://www.scopus.com/inward/record.url?scp=0030056419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030056419&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(96)90650-7

DO - 10.1016/S0190-9622(96)90650-7

M3 - Article

VL - 35

SP - 288

EP - 290

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2 II

ER -